Thomas, M., Ponce-Aix, S., Navarro, A., Riera-Knorrenschild, J., Schmidt, M., Wiegert, E., . . . Perez, J. (2018). Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase II IMPULSE study.
Citación estilo ChicagoThomas, M., et al. Immunotherapeutic Maintenance Treatment With Toll-like Receptor 9 Agonist Lefitolimod in Patients With Extensive-stage Small-cell Lung Cancer: Results From the Exploratory, Controlled, Randomized, International Phase II IMPULSE Study. 2018.
Cita MLAThomas, M., et al. Immunotherapeutic Maintenance Treatment With Toll-like Receptor 9 Agonist Lefitolimod in Patients With Extensive-stage Small-cell Lung Cancer: Results From the Exploratory, Controlled, Randomized, International Phase II IMPULSE Study. 2018.